Hans Biomed Corp 042520

KRX · South Korea · Health Services

KRW 21,250.00-1,300.00 (-5.76%)

Market closed· Oct 2, 2026, 6:30 AM UTC· KRW · Data may be delayed

Company news

Yahoo FinanceApr 01, 2026

Hugel to enter ECM-based injectable market with aesthetic portfolio expansion

Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has accelerated its growth strategy by adding an extracellular matrix (ECM)-based injectable treatment to its portfolio.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.